Navigation Links
Older Malarial Drugs Vs New Ones

In the 2000 World Health Organization (WHO) report it was stated that Malaria affects 300 to 500 million people every year across the world and is one of the leading// cause of illness and death in the sub-Saharan African countries. A new study conducted by Dr. Hasifa Bukirwa of the Uganda Malaria Surveillance Project and Julia Critchley of the Liverpool School of Tropical Medicine in England stated that older drugs showed better efficiency when used in the treatment of malaria in some parts of Africa.

The older drug is a combination of sulfadoxine-pyrimethamine (Fansidar) and amodiaquine. The new drug is a combination of Fansidar and artesunate. The researchers analyzed four studies including 775 malaria patients children age six months to five years and compared the Fansidar-amodiaquine treatment to Fansidar-artesunate therapy for mild to moderate cases of falciparum malaria.

After 28 days of treatment, there was a reduction (40%) in the number of cases of malaria among children who were taking a combination of the older sulfadoxine-pyrimethamine and amodiaquine than among patients taking a combination of Fansidar and artesunate (artemisinin).

But the new drug combination Fansidar-artesunate was more than twice as effective in clearing malarial parasites from the blood at a particularly stage of parasite development than the older drug combination. This step is important to prevent the spread of the disease. Hence the researcher feels that the older combination can be used to treat patient who have not developed resistance to the older drug combination and who lack access to the new drugs.

The results of the study are published in current issue of The Cochrane Library. The latest combination drug Artemisinin is very effective against multi-drug resistant strains of the falciparum type of malaria.

Artemisinin are not widely available in some of the African countries due to the low production, high cost, dosing c omplexity and the lack of clinical experience with artemisinin-based combinations.

Dr. David Bell, a malaria expert at the University of Liverpool in England said that in places where malaria is a major public health problem the old combination Fansidar-amodiaquine is not the treatment of choice.

Hence it is better to adopt the new combination drug therapy to treat malaria and save lives.
'"/>




Related medicine news :

1. Older men father schizophrenics
2. Creatine Helps Strengthen Older Men
3. Older Men Surviving Coronary Bypasses
4. Older womens heart health depends on location of fat
5. Older Breast Cancer Patients Can Be Effectively Treated With Chemotherapy
6. Frailty in Older Women may be due to Chronic Infection
7. Withdrawal Notice Issued For Older Pacemakers Due To Malfunctioning of the Device
8. Older People May Not Need Multivitamins To Prevent Infections
9. Gene Variation Associated With Better Mobility For Older Individuals
10. Older People Can Also Eat As Young!
11. Safe Driving Is Possible For Older People If They Are Prepared
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/20/2017)... ... ... Angel”: a heartwarming and earnest tale of faith and believing in the path ... the creation of published author, Marjorie Lund-Fontaine, a former professional violinist, alumnus of The ... of her new book, Marjorie says, “‘The Angel’ was written as a fairytale, but ...
(Date:1/20/2017)... ... ... “Christmas in Suffolk”: a story of love, secrets, and mystery. “Christmas in ... where she works in a daycare and looks for inspiration in the local coffee ... Publishing, Sara Seymour’s new book is an adventure of love and secrets. ...
(Date:1/20/2017)... ... January 20, 2017 , ... “God's Miracle Man: Against All Odds”: ... the creation of published author, Keith C. A. Tucker, son of Minister Delores Pinnock ... Outreach pastured by Reverend Mark Hardy , “While sitting up in bed, I felt ...
(Date:1/19/2017)... ... January 19, 2017 , ... Wells ... facility enhancement of their 503A compounding pharmacy located in Ocala, Florida. , ... physicians and patients throughout the United States for high-quality human anti-aging and ...
(Date:1/19/2017)... ... ... WhoHaha , a digital media company dedicated to creating and delivering female-centric, ... three-part video series that uses humor to highlight ways to improve heart health and ... For Good™ movement, which is designed to inspire all Americans to make small changes ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... CITY, Calif. , Jan. 19, 2017  Abaxis, ... company manufacturing point-of-care blood analysis instruments and consumables for ... conference call to discuss its financial results for the ... The call will be at 4:15 p.m. ET on ... results for the third quarter fiscal year 2017 after ...
(Date:1/19/2017)... CLEVELAND , Jan. 19, 2017 ViewRay, ... (DFG), a federal institution supporting research in ... installation and patient treatments at the University Clinic Heidelberg ... The MRIdian Linac program will be headed ... who also heads radiation oncology at the German Cancer ...
(Date:1/19/2017)... Pfizer joins Astex, AstraZeneca, ... Consortium   Major research investment to ...   The Milner Therapeutics Institute today ... a partner to the Milner Therapeutics Consortium. Pfizer has ... transfer of materials between industry and academia and allocation ...
Breaking Medicine Technology: